SCHEMBL24745343

SCHEMBL24745343

COC(=O)c1ccc(F)c(OCC(=O)OC(C)(C)C)c1CBr

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5AP P20292 1/20 0.34
▸ FEN1 P39748 1/20 0.34
▸ ATR Q13535 1/20 0.34
▸ PSEN1 P49768 1/20 0.34
▸ PSEN2 P49810 1/20 0.34
▸ APH1B Q8WW43 1/20 0.34
▸ NCSTN Q92542 1/20 0.34
▸ APH1A Q96BI3 1/20 0.34
▸ PSENEN Q9NZ42 1/20 0.34
▸ CTSK P43235 1/20 0.32
▸ MTNR1A P48039 1/20 0.32
▸ MTNR1B P49286 1/20 0.32
▸ MEN1 O00255 3/20 0.31
▸ KMT2A Q03164 3/20 0.31
▸ ACLY P53396 2/20 0.31
▸ GAA P10253 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ CFTR P13569 1/20 0.31
▸ POLB P06746 1/20 0.30
▸ MCOLN3 Q8TDD5 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24745526 0.86 ATR (0.39) ATRPSEN1PSEN2APH1BNCSTN
SCHEMBL24745340 0.84 ALOX5AP (0.36) ALOX5APFEN1ATRPSEN1PSEN2
SCHEMBL30121844 0.84 ALOX5AP (0.36) ALOX5APFEN1ATRPSEN1PSEN2
SCHEMBL24744883 0.76 MTNR1A (0.34) ATRPSEN1PSEN2APH1BNCSTN
SCHEMBL6645891 0.75 KDM4E (0.39) ALOX5APFEN1ATRPSEN1PSEN2
SCHEMBL24745569 0.74 MTNR1A (0.42) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL8729538 0.73 CES2 (0.44) KMT2AGAACFTRPOLBMCOLN3
SCHEMBL20510109 0.73 FFAR4 (0.52) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL885340 0.73 ALDH1A1 (0.46) MTNR1AMTNR1BMEN1KMT2AL3MBTL1
SCHEMBL30938988 0.72 ALDH1A1 (0.36) ATRPSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4347579-A1 TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN Captor Therapeutics S.A. (PL) 2024-04-10 — — EP disclosed
WO-2022253713-A1 TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN CAPTOR THERAPEUTICS S.A. (PL) 2022-12-08 — — WO disclosed
WO-2022253713-A1 TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN CAPTOR THERAPEUTICS S.A. (PL) 2022-12-08 — — WO disclosed
Send feedback